Standardised self-management kits for children with type 1 diabetes: pragmatic randomised trial of effectiveness and cost-effectiveness

Author:

Noyes JaneORCID,Allen Davina,Carter Cynthia,Edwards Deborah,Edwards Rhiannon Tudor,Russell Daphne,Russell Ian T,Spencer Llinos Haf,Sylvestre Yvonne,Whitaker Rhiannon,Yeo Seow Tien,Gregory John W

Abstract

ObjectiveTo estimate the effectiveness of standardised self-management kits for children with type 1 diabetes.DesignPragmatic trial with randomisation ratio of two intervention: one control. Qualitative process evaluation.Setting11 diabetes clinics in England and Wales.ParticipantsBetween February 2010 and August 2011, we validly randomised 308 children aged 6–18 years; 201 received the intervention.InterventionWe designed kits to empower children to achieve glycaemic control, notably by recording blood glucose and titrating insulin. The comparator was usual treatment.Outcome measures at 3 and 6 monthsPrimary: Diabetes Pediatric Quality of Life Inventory (PedsQL). Secondary: HbA1c; General PedsQL; EQ-5D; healthcare resource use.ResultsOf the five Diabetes PedsQL dimensions, Worry showed adjusted scores significantly favouring self-management kits at 3 months (mean child-reported difference =+5.87; Standard error[SE]=2.19; 95% confidence interval [CI]) from +1.57 to +10.18; p=0.008); but Treatment Adherence significantly favoured controls at 6 months (mean child-reported difference=−4.68; SE=1.74; 95%CI from −8.10 to −1.25; p=0.008). Intervention children reported significantly worse changes between 3 and 6 months on four of the five Diabetes PedsQL dimensions and on the total score (mean difference=−3.20; SE=1.33; 95% CI from −5.73 to −0.67; p=0.020). There was no evidence of change in HbA1c; only 18% of participants in each group achieved recommended levels at 6 months. No serious adverse reactions attributable to the intervention or its absence were reported.Use of kits was poor. Few children or parents associated blood glucose readings with better glycaemic control. The kits, costing £185, alienated many children and parents.ConclusionsStandardised kits showed no evidence of benefit, inhibited diabetes self-management and increased worry. Future research should study relationships between children and professionals, and seek new methods of helping children and parents to manage diabetes.Trial registration numberNCT17551624.

Funder

Health Services and Delivery Research Programme

Publisher

BMJ

Subject

General Medicine

Reference37 articles.

1. NHS Digital . National diabetes audit, 2015-16 report 2A: complications and mortality (complications of diabetes) England and Wales 2017. Available: https://files.digital.nhs.uk/pdf/4/t/national_diabetes_audit__2015-16__report_2a.pdf

2. International Society for pediatric and adolescent diabetes. ISPAD clinical practice consensus guidelines 2009. Available: www.ispad.org/resource-type/ispad-clinical-practice-consensus-guidelines- 2009 [Accessed 10.3, 2013].

3. National Institute for Health and Care Excellence . Type 1 diabetes: diagnosis and management of type 1 diabetes in children and young people. London: National Institute for Clinical Excellence, 2004.

4. Royal College of paediatrics and child health (RCPCH) . Growing up with diabetes: children and young people with diabetes in England. London: RCPCH, 2009.

5. Scottish Intercollegiate Guidelines Network . Management of diabetes: a national clinical guideline 2010;116.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3